semaglutide orem Oral for Weight Loss Semaglutide Weight Management | ​​Face

GLP-1 drugs slow gastric emptying, reducing hunger and portion size

Senders ML, Calcagno C, Tawakol A, Nahrendorf M, Mulder WJM, Fayad ZA

These studies reveal that GLP-1 RAs not only decrease oxidative stress and inflammation in endothelial cells but also inhibit cardiac hypertrophy and fibrosis by regulating myocardial proliferation and apoptosis [76]

Serious but rare gastrointestinal complications that require medical attention include: Pancreatitis (rare but requires immediate medical attention) Gallbladder disease including cholecystitis (risk may be increased with rapid weight loss) Severe delayed gastric emptying Intestinal obstruction or ileus (FDA labels for semaglutide include postmarketing reports of ileus) These conditions require prompt evaluation but are not cancer-related